PuriCore Share Price (PURI)

30.75 -0.75 (-2.38%) delayed: 9:28AM BST
Bid price 30.00 Open price 31.50
Ask price 31.50 Prev close 30.75
High price 31.20 Spread 4.76%
Low price 31.00 Volume 60,000

Register now for FREE live PuriCore share prices, PuriCore stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get PuriCore Level 2 Data, indepth research tools and investor commentary for PuriCore (PURI) and other London Stock Exchange equities.

PuriCore Share Price Chart

Advanced Charts >>

Register now for FREE PuriCore share price charts

PuriCore Share Price Information

Name PuriCore Epic PURI
Sector Health Care Equipment & Services ISIN GB00B3XBCR18
Activites PuriCore develops and commercializes proprietary products that safely, effectively, and naturally kill contagious pathogens including major public health threats—M.tuberculosis, MRSA, E.coli, norovirus, avian influenza, HIV, polio virus, Helicobater pylori, and Legionella. Our products generate hypochlorous acid, the same natural anti-microbial produced by the human body to fight pathogens. Hypochlorous acid is highly effective in killing all types of bacteria, viruses, and fungal spores. PuriCore's technology and solutions are used in a broad range of markets that depend upon controlling contamination, including endoscopy, food retail, foodservice, hospitality, institutional, and wound therapy. Our antimicrobial solution is deployed as soaks, sprays, mists, and in other forms to limit the spread of infectious disease. The patented technologies use a simple combination of water, salt, and electricity to produce the same powerful solution found in the human immune system. PuriCore's highly sophisticated processes and controls allow the production of these unique biocidal solutions with a variety of different chemical and microbiological properties for use in specific settings and applications. Index n/a

PuriCore Key Numbers

Latest Share Price (p) 30.75 Net Gearing (%) -55.95
Market Capitalisation (£m) 15.79 Gross Gearing (%) 10.19
Shares in issue (m) 50.14 Debt Ratio 0.00
P/E Ratio 1.09 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.11
Dividend Yield (%) 0.00 Price to book value 0.56
Dividend cover (x) 0.00 ROCE -0.69
Earning per share (p) 29.00 EPS Growth (%) 323.08
52 week high / low 54.50 / 27.50 DPS Growth (%) n/a

PuriCore Director Deals

Dec.Date Type Director Pos No. of Shares
02/04/2015 BUY Charles Spicer CH 50,610
12/08/2014 BUY Michael Ashton CEO 50,000
12/08/2014 BUY Michael Ashton CEO 100,000
01/11/2013 BUY Daniel Hegglin NED 1,000,000
06/09/2013 BUY Daniel Hegglin NED 50,000

More PuriCore Director Deals >>

PuriCore Company News

09:00 02/04/2015

Director Deals - PuriCore PLC (PURI)

Charles Spicer, Chairman, bought 50,610 shares in the company on the 1st April 2015 at a price of 32.00p. The Director now holds 75,000 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com

07:00 02/04/2015

Director Dealing

/* */ RNS Number : 2552J PuriCore Plc 02 April 2015    PuriCore plc ("PuriCore" or the "Company")   Director Dealing   2 April 2015 - PuriCore plc (AIM: PURI) , an international company focused on safe and effective...

07:42 31/03/2015

PuriCore narrows FY pretax loss

PuriCore has narrowed its FY pretax loss to $7.0m, from a loss of $8.6m. Revenue totalled $17.1m, from $31.5m. CEO Michael Ashton said: "This year represented a turning-point for PuriCore. We successfully completed the sale of our UK Endoscopy business for net proceeds of $25.6 million and we...

More PuriCore Company News >>

Register now for FREE PuriCore company news

PuriCore Share Price Discussions

1 months ago

PuriCore plc (PURI)

PuriCore specializes in developing and commercializing solutions to protect against the spread of infectious pathogens. Our proprietary products are effective while being completely safe for human and animal health and the environment. PuriCore has broad experience in key markets that...

more than 1 year ago

Puricore - US FDA approval and US Supermarket interest (PURI)

This one has come to my attention after a sudden surge from the bottom of its price range. In the last two weeks, PURI has announced US FDA approval to market its Sterilox Endoscopy High-Level Disinfectant System as a medical device in the US; also announced first prelims showing increasing...

Register now for FREE PuriCore share price discussions